The cuts at two Massachusetts plants follow further site closures and layoffs across the company over the past few years.

Telethon Foundation is seeking approval for a gene therapy to treat the rare disease Wiskott-Aldrich syndrome.

Every technological revolution has a defining moment when a specific use case propels the technology into widespread adoption. That time has come for generative AI (GenAI) with the rapid spread of ...

Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...

CARGO elects to discontinue FIRCE-1, a Phase 2 clinical study of firicabtagene autoleucel (firi-cel)1; Company believes results do not support a ...

The arrival of Industry 5.0 has opened up the ability for manufacturers to "see" in real-time the detailed relationship of ...

Transgene's programs utilize viral vector technology with the goal of indirectly or ... the ability to obtain financing and/or partnerships for product manufacturing, development and commercialization ...

Transgene’s programs utilize viral vector technology with the goal of indirectly or ... the ability to obtain financing and/or partnerships for product manufacturing, development and commercialization ...

Natural insecticide developer has won $3 million of US military grants to tackle the problems of mosquito-borne diseases, ...